In serum level, our results showed that the serum EMMPRIN showed a remarkable elevation in NSCLC patients, as compared with control group, thus meaning a possible correlation between the increase of EMMPRIN level and an upward risk of NSCLC. This evidence concerns the gene BSG and non-small cell lung carcinoma.